论文部分内容阅读
重组人粒细胞巨噬细胞集落刺激因子（ｒｈＧＭ－ＣＳＦ商品名利百多）同以往报道较多的粒细胞集落刺激因子（Ｇ－ＣＳＦ）对肿瘤化疗引起的白细胞减少均有良好的预防和治疗作用，已成为恶性肿瘤化疗的重要辅助治疗手段。本文总结了７３例实体瘤化疗中应用利百多的情况，现报告
Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF trade name, Rebaudioside) has been reported to have good preventive and therapeutic effects on neutropenia caused by chemotherapy in combination with granulocyte colony-stimulating factor (G-CSF), which has been reported in the past. , Has become an important adjuvant treatment for cancer chemotherapy. This article summarizes the use of Ribido in 73 cases of solid tumor chemotherapy.